Topics

Evotec spin-off to develop cancer drugs using DDR pathway

19:00 EDT 8 Jul 2019 | Pharmaceutical Technology

Evotec has formed spin-off company Breakpoint Therapeutics to focus on the development of its DNA damage response (DDR) portfolio. The...
Read More...

The post Evotec spin-off to develop cancer drugs using DDR pathway appeared first on Pharmaceutical Technology.

Original Article: Evotec spin-off to develop cancer drugs using DDR pathway

NEXT ARTICLE

More From BioPortfolio on "Evotec spin-off to develop cancer drugs using DDR pathway"

Quick Search

Relevant Topic

Bioinformatics
Bioinformatics is the application of computer software and hardware to the management of biological data to create useful information. Computers are used to gather, store, analyze and integrate biological and genetic information which can then be applied...